$INTS

INTENSITY THERAPEUTICS, INC.

No enriched coverage for $INTS in the last 7 days.

No SEC Form 4 filings for $INTS in the last 30 days.

Low

Intensity Therapeutics boosts ATM capacity to $60.0M to enhance financing flexibility

Intensity Therapeutics (INTS) has increased its at-the-market (ATM) offering capacity to $60.0 million to improve its financial flexibility. This allows the company to issue common stock, though it is not obligated to sell shares, maintaining discretion based on market conditions and strategy. The ATM program is conducted with H.C. Wainwright & Co. as the sales agent, as detailed in an SEC filing from March 23, 2026.

Intensity Therapeutics (NASDAQ: INTS) boosts $60M at-the-market capacity

Intensity Therapeutics, Inc. has increased its at-the-market (ATM) stock offering program capacity to $60.0 million. This expansion provides the company with greater financial flexibility to raise equity capital through the sale of common shares via H.C. Wainwright & Co. LLC, although the company is not obligated to issue any shares. The decision to utilize the ATM program will depend on market conditions and the company's strategic priorities.

Intensity Therapeutics (NASDAQ: INTS) raises ATM capacity to $60M

Intensity Therapeutics (NASDAQ:INTS) has increased its At-The-Market (ATM) offering capacity to $60 million, effective March 23, 2026, by supplementing its July 11, 2024 sales agreement. The company has already sold 1,297,655 shares under the previous agreement, totaling $12,029,360 in gross sales. H.C. Wainwright & Co., LLC continues to act as the agent for the ATM offering, with all other terms of the agreement remaining unchanged.